Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Heron Therapeutics (HRTX) over the last 12 years, with Q3 2025 value amounting to 0.64.

  • Heron Therapeutics' Asset Utilization Ratio rose 274.25% to 0.64 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.64, marking a year-over-year increase of 274.25%. This contributed to the annual value of 0.63 for FY2024, which is 1800.85% up from last year.
  • According to the latest figures from Q3 2025, Heron Therapeutics' Asset Utilization Ratio is 0.64, which was up 274.25% from 0.64 recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Asset Utilization Ratio registered a high of 0.64 during Q3 2025, and its lowest value of 0.23 during Q3 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.48, with a median of 0.56 in 2023.
  • In the last 5 years, Heron Therapeutics' Asset Utilization Ratio plummeted by 1583.42% in 2021 and then skyrocketed by 6705.78% in 2022.
  • Heron Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.26 in 2021, then soared by 56.94% to 0.41 in 2022, then skyrocketed by 36.59% to 0.56 in 2023, then increased by 13.02% to 0.64 in 2024, then rose by 1.43% to 0.64 in 2025.
  • Its Asset Utilization Ratio was 0.64 in Q3 2025, compared to 0.64 in Q2 2025 and 0.63 in Q1 2025.